BNP PARIBAS ASSET MANAGEMENT Holding S.A. trimmed its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 48.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 110,318 shares of the company's stock after selling 104,728 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned about 0.05% of Docusign worth $8,979,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in DOCU. Wellington Management Group LLP grew its position in shares of Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after acquiring an additional 1,440,269 shares during the period. Jericho Capital Asset Management L.P. boosted its holdings in Docusign by 34.0% in the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after purchasing an additional 1,205,500 shares during the period. Pacer Advisors Inc. boosted its holdings in Docusign by 809.6% in the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock valued at $95,017,000 after purchasing an additional 1,038,962 shares during the period. Northern Trust Corp boosted its holdings in Docusign by 77.2% in the 4th quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock valued at $178,475,000 after purchasing an additional 864,408 shares during the period. Finally, Nuveen LLC bought a new stake in shares of Docusign during the 1st quarter worth approximately $50,459,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
DOCU has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Morgan Stanley lowered their price objective on Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, June 6th. Wedbush lowered their target price on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a report on Thursday, June 12th. Wall Street Zen downgraded Docusign from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Finally, Bank of America decreased their price objective on Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a report on Friday, June 6th. Four investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $89.77.
Get Our Latest Stock Report on DOCU
Insider Buying and Selling
In other news, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the transaction, the insider owned 72,126 shares in the company, valued at $5,394,303.54. This trade represents a 24.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm's stock in a transaction that occurred on Wednesday, June 18th. The shares were sold at an average price of $74.80, for a total value of $1,132,696.40. Following the completion of the transaction, the chief financial officer owned 110,723 shares of the company's stock, valued at approximately $8,282,080.40. The trade was a 12.03% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 78,552 shares of company stock valued at $5,983,631 in the last 90 days. 1.01% of the stock is owned by insiders.
Docusign Price Performance
Shares of NASDAQ DOCU traded up $4.07 during trading on Friday, reaching $74.81. 2,692,758 shares of the stock traded hands, compared to its average volume of 2,172,880. Docusign Inc. has a 52-week low of $54.31 and a 52-week high of $107.86. The company has a 50-day moving average of $75.47 and a 200-day moving average of $80.39. The stock has a market capitalization of $15.12 billion, a P/E ratio of 14.14, a price-to-earnings-growth ratio of 26.40 and a beta of 1.01.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million for the quarter, compared to analyst estimates of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.82 EPS. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts expect that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.
Docusign announced that its board has approved a share buyback program on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to buy up to 6.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.
Docusign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report